Citation Impact
Citing Papers
The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci
1989
Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2.
2000
The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
1999
Cancer chemoprevention through dietary flavonoids: what’s limiting?
2017
A review on plant-based rutin extraction methods and its pharmacological activities
2013 Standout
Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms
2001 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Flavan‐3‐ols: Nature, occurrence and biological activity
2007
Xanthohumol and related prenylflavonoids from hops and beer: to your good health!
2004 Standout
Oxidative Inactivation of Cytochrome P-450 1A (CYP1A) Stimulated by 3,3′,4,4′-Tetrachlorobiphenyl: Production of Reactive Oxygen by Vertebrate CYP1As
1999
Health effects of quercetin: From antioxidant to nutraceutical
2008 Standout
Interactions of Herbs with Cytochrome P450
2003
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
CYP2E1 and oxidative liver injury by alcohol
2007
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Seleno-compounds in garlic and onion
2006
The Toxicokinetics and Metabolism of Polychlorinated Dibenzo-p-Dioxins (PCDDs) and Dibenzofurans (PCDFs) and Their Relevance for Toxicity
1994
Flavonoids as prospective compounds for anti-cancer therapy
2013
Differential Mechanisms of Cytochrome P450 Inhibition and Activation by α-Naphthoflavone
1997
Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2
1999
Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids—Structural Requirements
2002
Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat
1999
Progression of Alcoholic and Non-alcoholic Steatohepatitis: Common Metabolic Aspects of Innate Immune System and Oxidative Stress
2010
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
2009 Standout
Alcohol-induced oxidative stress
2007
Porphyrias
2010 Standout
New horizons in the extraction of bioactive compounds using deep eutectic solvents: A review
2017 Standout
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Flavonoids: A versatile source of anticancer drugs
2011 Standout
Molecular mechanisms of quinone cytotoxicity
1991 Standout
Contaminant-stimulated Reactive Oxygen Species Production and Oxidative Damage in Aquatic Organisms
2001 Standout
Dietary flavonoid apigenin is a potential inducer of intracellular oxidative stress: The role in the interruptive apoptotic signal
2007
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
2002 Standout
CYP2E1: from ASH to NASH
2003
Alcoholic liver disease: New insights in pathogenesis lead to new treatments
2000
The biochemistry and medical significance of the flavonoids
2002 Standout
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus
2000
Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships
2002 Standout
Porphyria Cutanea Tarda: Multiplicity of Risk Factors Including HFE Mutations, Hepatitis C, and Inherited Uroporphyrinogen Decarboxylase Deficiency
2002
Polyphenols: food sources and bioavailability
2004 Standout
Recent advances in the transcriptional regulation of the flavonoid biosynthetic pathway
2011 Standout
Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism
2005
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
2004 Standout
Fish bioaccumulation and biomarkers in environmental risk assessment: a review
2002 Standout
Flavonoids: Promising anticancer agents
2003 Standout
Chemistry and Biological Activities of Flavonoids: An Overview
2013 Standout
Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions
2004 Standout
Pharmacognostic and pharmacological profile of Humulus lupulus L.
2008 Standout
Flavonoids: an overview
2016 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Herb-Drug Interactions
2005 Standout
Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance
2009 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon?
2006 Standout
Interactions Between Herbal Medicines and Prescribed Drugs
2001 Standout
Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1
2000
The 2005 World Health Organization Reevaluation of Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like Compounds
2006 Standout
Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells
1999
Inhibition of 7-ethoxycoumarinO-deethylase activity in rat liver microsomes by naturally occurring flavonoids: structure-activity relationships
1998
The Myofibroblast
2007 Standout
Differential Effects of Nonhydroxylated Flavonoids as Inducers of Cytochrome P450 1A and 2B Isozymes in Rat Liver
1996
Absorption and metabolism of flavonoids
2004
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
2010 Standout
Biological properties of onions and garlic
2007 Standout
Efflux of Dietary Flavonoid Quercetin 4′-β-Glucoside across Human Intestinal Caco-2 Cell Monolayers by Apical Multidrug Resistance-Associated Protein-2
2000
Male reproductive health and environmental xenoestrogens.
1996 Standout
Determination of Antioxidants by DPPH Radical Scavenging Activity and Quantitative Phytochemical Analysis of Ficus religiosa
2022 Standout
Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids
1996
Extensive Binding of the Bioflavonoid Quercetin to Human Plasma Proteins
1998
Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme.
1995
Fate of the Flavonoid Quercetin in Human Cell Lines: Chemical Instability and Metabolism
1999
Update on Uses and Properties of Citrus Flavonoids: New Findings in Anticancer, Cardiovascular, and Anti-inflammatory Activity
2008 Standout
Relationships between nutrition, alcohol use, and liver disease.
2003
Flavonoids as Antioxidants
2000 Standout
Microsomal and photochemical oxidation and reduction of 1-piperidinoanthraquinone
1982
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
CYP2E1 – Biochemical and Toxicological Aspects and Role in Alcohol-Induced Liver Injury
2008
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Prenylflavonoids from Hops Inhibit the Metabolic Activation of the Carcinogenic Heterocyclic Amine 2-Amino-3-methylimidazo[4,5-f]quinoline, Mediated by cDNA-Expressed Human CYP1A2
2000
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Flavonoids as Potent Scavengers of Hydroxyl Radicals
2016
Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids.
1998
Heme-Containing Oxygenases
1996 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Ubiquinol regeneration by plasma membrane ubiquinone reductase
1998
Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids.
1996
Variation in CYP1A2 Activity and its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms
2008
Repeated Oral Administration of High Doses of the Pomegranate Ellagitannin Punicalagin to Rats for 37 Days Is Not Toxic
2003 Standout
Works of Tsyrlov Ib being referenced
Stimulatory effect of the CYPlAl inducer 2,3,7,8-tetrachlorodibenzo-pdioxin on the reproduction of HIV-1 in human lymphoid cell culture
1993
Interspecies features of hepatic cytochromes P450 IA1 and P450 IA2 in rodents
1990
Enzyme-Kinetic and Immunochemical Characteristics of Mouse cDNA-Expressed, Microsomal, and Purified CYP1A1 and CYP1A2
1993
Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids
1994
2,3,7,8-Tetrachlorodibenzo-p-dioxin as a possible activator of HIV infection
1991
Uroporphyrinogen oxidation catalyzed by human cytochromes P450.
1998
Reactions of Phenoxyl Radicals with NADPH-Cytochrome P-450 Oxidoreductase and NADPH: Reduction of the Radicals and Inhibition of the Enzyme
1997
Respective Roles of Human Cytochrome P‐4502E1, 1A2, and 3A4 in the Hepatic Microsomal Ethanol Oxidizing System
1998
Possible mechanism of induction of liver microsomal monooxygenases by phenobarbital☆
1976
Effect of TCDD and comparable inducers upon synthesis of monooxygenase forms P-450c and P-450d in rats
1989